Development of a novel diagnostic model to monitor the progression of metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma in females

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  PubMed  Google Scholar 

El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27. https://doi.org/10.1056/NEJMra1001683.

Article  CAS  PubMed  Google Scholar 

Foerster F, Gairing SJ, Muller L, Galle PR. NAFLD-driven HCC: safety and efficacy of current and emerging treatment options. J Hepatol. 2022;76:446–57. https://doi.org/10.1016/j.jhep.2021.09.007.

Article  CAS  PubMed  Google Scholar 

Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gomez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, Group NNc. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966–86. https://doi.org/10.1097/HEP.0000000000000520.

Article  PubMed  Google Scholar 

Nagral A, Bangar M, Menezes S, Bhatia S, Butt N, Ghosh J, Manchanayake JH, Mahtab MA, Singh SP. Gender differences in nonalcoholic fatty liver disease. Euroasian J Hepatogastroenterol. 2022;12:S19-25. https://doi.org/10.5005/jp-journals-10018-1370.

Article  PubMed  PubMed Central  Google Scholar 

Pramfalk C, Pavlides M, Banerjee R, McNeil CA, Neubauer S, Karpe F, Hodson L. Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher propensity for NAFLD in men. J Clin Endocrinol Metab. 2015;100:4425–33. https://doi.org/10.1210/jc.2015-2649.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Link JC, Reue K. Genetic basis for sex differences in obesity and lipid metabolism. Annu Rev Nutr. 2017;37:225–45. https://doi.org/10.1146/annurev-nutr-071816-064827.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Zheng J, Hao J, Wang RR, Liu X, Gu P, Yu H, Yu Y, Wu C, Ou B, Peng Z. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019. Cancer Med. 2022;11:1310–23. https://doi.org/10.1002/cam4.4551.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu EM, Wong LL, Hernandez BY, Ji JF, Jia W, Kwee SA, Kalathil S. Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation. Hepatoma Res. 2018;4. https://doi.org/10.20517/2394-5079.2018.87.

Singal AG, Yopp AC, Gupta S, Skinner CS, Halm EA, Okolo E, Nehra M, Lee WM, Marrero JA, Tiro JA. Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila). 2012;5:1124–30. https://doi.org/10.1158/1940-6207.CAPR-12-0046.

Article  PubMed  Google Scholar 

Stine JG, Wentworth BJ, Zimmet A, Rinella ME, Loomba R, Caldwell SH, Argo CK. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases. Aliment Pharmacol Ther. 2018;48:696–703. https://doi.org/10.1111/apt.14937.

Article  PubMed  PubMed Central  Google Scholar 

Lupsor-Platon M, Serban T, Silion AI, Tirpe A, Florea M. Hepatocellular carcinoma and non-alcoholic fatty liver disease: a step forward for better evaluation using ultrasound elastography. Cancers. 2020;12:2778. https://doi.org/10.3390/cancers12102778.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mallela VR, Rajtmajerova M, Trailin A, Liska V, Hemminki K, Ambrozkiewicz F. miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma. Noncoding RNA Res. 2024;9:24–32. https://doi.org/10.1016/j.ncrna.2023.10.010.

Article  CAS  PubMed  Google Scholar 

Liu M, Zhang Z, Zhang W, Liu SM. Advances in biomarker discovery using circulating cell-free DNA for early detection of hepatocellular carcinoma. WIREs Mech Dis. 2023;15: e1598. https://doi.org/10.1002/wsbm.1598.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shetti D, Mallela VR, Ye W, Sharif M, Ambrozkiewicz F, Trailin A, Liska V, Hemminki K. Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma. Crit Rev Oncol Hematol. 2024;200: 104391. https://doi.org/10.1016/j.critrevonc.2024.104391.

Article  PubMed  Google Scholar 

Zheng Y, Gao K, Gao Q, Zhang S. Glycoproteomic contributions to hepatocellular carcinoma research: a 2023 update. Expert Rev Proteomics. 2023;20:211–20. https://doi.org/10.1080/14789450.2023.2265064.

Article  CAS  PubMed  Google Scholar 

Chang D, Truong E, Mena EA, Pacheco F, Wong M, Guindi M, Todo TT, Noureddin N, Ayoub W, Yang JD, Kim IK, Kohli A, Alkhouri N, Harrison S, Noureddin M. Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis. Hepatology. 2023;77:546–57. https://doi.org/10.1002/hep.32655.

Article  CAS  PubMed  Google Scholar 

Gan X, Luo Y, Dai G, Lin J, Liu X, Zhang X, Li A. Identification of gene signatures for diagnosis and prognosis of hepatocellular carcinomas patients at early stage. Front Genet. 2020;11:857. https://doi.org/10.3389/fgene.2020.00857.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23:1846–7. https://doi.org/10.1093/bioinformatics/btm254.

Article  CAS  PubMed  Google Scholar 

Kauffmann A, Rayner TF, Parkinson H, Kapushesky M, Lukk M, Brazma A, Huber W. Importing ArrayExpress datasets into R/Bioconductor. Bioinformatics. 2009;25:2092–4. https://doi.org/10.1093/bioinformatics/btp354.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat Protoc. 2009;4:1184–91. https://doi.org/10.1038/nprot.2009.97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li R, Qu H, Wang S, Wei J, Zhang L, Ma R, Lu J, Zhu J, Zhong WD, Jia Z. GDCRNATools: an R/Bioconductor package for integrative analysis of lncRNA, miRNA and mRNA data in GDC. Bioinformatics. 2018;34:2515–7. https://doi.org/10.1093/bioinformatics/bty124.

Article  CAS  PubMed  Google Scholar 

Lian Q, Wang S, Zhang G, Wang D, Luo G, Tang J, Chen L, Gu J. HCCDB: a database of hepatocellular carcinoma expression atlas. Genomics Proteomics Bioinformatics. 2018;16:269–75. https://doi.org/10.1016/j.gpb.2018.07.003.

Article  PubMed  PubMed Central  Google Scholar 

Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118–27. https://doi.org/10.1093/biostatistics/kxj037.

Article  PubMed  Google Scholar 

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43: e47. https://doi.org/10.1093/nar/gkv007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kolde R, Laur S, Adler P, Vilo J. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics. 2012;28:573–80. https://doi.org/10.1093/bioinformatics/btr709.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen H, Boutros PC. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics. 2011;12:35.

留言 (0)

沒有登入
gif